Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Antifungals Market From 2025 To 2029?

Over recent years, there has been robust growth in the size of the antifungals market. It is expected to increase from $27.01 billion in 2024 to $29.67 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.8%. The expansion during the historic period can be ascribed to factors such as the incidence of fungal diseases, the aging populace, development of healthcare infrastructure, and heightened awareness and education.

What Is the Projected Market Size of the Antifungals Market?

In the coming years, significant expansion is anticipated in the antifungals market. It is projected to swell to $41.84 billion by 2029, with a compound annual growth rate (CAGR) of 9.0%. This predicted growth during the forecast period can be put down to various factors including the emergence of new fungal strains, regulatory approvals, worldwide health worries, heightened spending on healthcare, and improved patient knowledge and awareness. The main trends expected to dominate the forecast period comprise research and development efforts, the rise of telemedicine and e-health, breakthroughs in the development of antifungal drugs, and collaborations and partnerships.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2442&type=smp

Who are the Major Competitors in the Antifungals Market Outlook?

Major companies operating in the antifungals market include Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline plc, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc, Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company plc, Wockhardt Ltd., Lupin Limited, Dr. Reddy’s Laboratories Ltd, Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited

What Is Fueling Growth in the Antifungals Market?

The rise in fungal infections is anticipated to boost the antifungals market’s expansion. Fungal infections, diseases triggered by the infiltration and proliferation of fungi in or on the body, can impact several body parts including skin, nails, lungs, and mucous membranes. The surge of these infections can be attributed to factors like a growing number of individuals with compromised immune systems, climate change that supports fungal growth, disruption of natural microbiomes due to extensive use of broad-spectrum antibiotics, inadequate hygiene, urbanization, and a rising prevalence of chronic diseases like diabetes that make individuals more susceptible to fungal infections. Antifungals are essential in fighting fungal diseases as they hinder the development and reproduction of fungi by disrupting their cell wall or membrane, blocking crucial enzymatic processes, or obstructing the synthesis of vital components, thereby diminishing fungal load, relieving symptoms, and curtailing the spread of infection within the body. For example, in September 2024, the International Society For Infectious Diseases, a US-based non-profit organization, reported an annual incidence of 6.5 million invasive fungal infections, associated with roughly 3.8 million deaths, 2.5 million (68%; range 35-90%) of which are directly connected to these infections. As such, the escalating incidence of fungal infections is projected to fuel the antifungals market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2442&type=smp

Which Antifungals Market Segments Are Growing the Fastest?

The antifungals market covered in this report is segmented –

1) By Drug Type: Echinocandins, Azoles, Polyenes, Allylamines

2) By Route of Administration: Oral, Parenteral, Topical

3) By End users: Hospitals & Clinics, Dermatology clinics, Other Users

Subsegments

1) By Echinocandins: Caspofungin, Micafungin, Anidulafungin

2) By Azoles: Fluconazole, Itraconazole, Voriconazole, Posaconazole, Ketoconazole

3) By Polyenes: Amphotericin B, Nystatin

4) By Allylamines: Terbinafine, Naftifine

Which Industry Trends Are Shaping the Future of the Antifungals Market?

Pharmaceutical developers and producers are expanding departments like research and development, marketing, and production by forming alliances and strategic partnerships with other businesses and research organizations, with the aim of augmenting their range of products. Therefore, to enhance their revenues and maintain their competitiveness in the anti-infective drugs market, companies should take into account forming strategic collaborations to broaden their reach and diversify their product offerings.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antifungals-global-market-report

Which Countries Are Leading the Antifungals Market?

North America was the largest region in the drugs for antifungals market in 2023. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2442

This Report Delivers Insight On:

1. How big is the antifungals market, and how is it changing globally?

2. Who are the major companies in the antifungals market, and how are they performing?

3. What are the key opportunities and risks in the antifungals market right now?

4. Which products or customer segments are growing the most in the antifungals market?

5. What factors are helping or slowing down the growth of the antifungals market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model